版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
NephroticSyndromeDepartmentofPrdiatrics,TongjiHospitalNephroticSyndrome
DefinitionEtiologyPathologyPathophysiologyClinicalManifestationLaboratoryDataDiagnosisTherapyandPrognosis
Male4yearsand6monthsoldComplaintofedemaandoliguriaDefinition:NephroticCriteria
MassiveproteinuriaISKDC:>40mg/m2/hrCAN:>+++trice/2wor>50-100mg/kg/24hrMendoza:UrineProtein/Cr≥2.0Hypoalbuminemia:<30g/LHyperlipidemia:Cholesterol>5.72mmol/LEdemaDefinition:NephriticCriteriaHematuria:RBC++(>10/HP),trice/2wHypertension:>130/90mmHginchildrenover7y>120/80mmHgin3-6ychildren>110/70mmHgin<3ychildrenAzotemia:BUN>6.4mmol/L,Cr>133umol/LHypocomplementemia:C3<0.8/LDefinitionNephriticNephrosis:nephroticcriteriawithatleastonenephriticcriteriaSimplenephrosis:nephroticcriteriawithoutnephriticcriteriaEtiologyCongenitalNS:rareIdiopathicNS:majoritySecondaryNS:manycausesespeciallyin<3yor>13ypatients
causes―DIAMONDMinimalChangeNephropathy(MCN)LittleornomicroscopicabnormalityAbsenceofimmunecomplexesEffacementofepithelialfootprocessOccasionallymesangialhypercellurity
MCN:normalinLMMCN:effacementofepithelialfootprocessinEMMesangialproliferativeglomerulonephritis(MsPGN)
MesangialproliferationandexpansionIgG,C3andsometimesIgA,IgMdepositsinmesangialstalkElectron-densedepositsinmesangialorparamesangialareasMsPGN:
MesangialproliferationandexpansionIgGandC3depositsinmesangialMesangialproliferativeglomerulonephritis(MsPGN)
MesangialproliferationandexpansionIgG,C3andsometimesIgA,IgMdepositsinmesangialstalkElectron-densedepositsinmesangialorparamesangialareasFocalsegmentalglomerulosclerosis(FSGS)FocalandsegmentalcapillarycollapseandmesangialsclerosisDepositsofIgMorC3intheglomeruliLossofvisceralepithelialcellpodocytes,duplicationofthebasalGBMlamina,separationofepithelialcellfromGBMMembranousNephropathy(MN)DiffuseGBMthickening,characteristicGBMspikesSubepithelialdepositofIgGandC3Membraneproliferativeglomerulonephritis(MPGN)MesangialproliferationandexpansionSubendothelialmesangialinterposition,tramtrackapperanceMesangialandsubendothelialdepositsofIgGandC3Pathophysiologyofnephroticsyndrome
MCN:InvolvementofimmunesystemNoIgorcomplementdepositAssociationbetweenallegyandidiopathicNSAbnormalitiesofhumuralandcellularimmunity:IgG↓,IgA↓,CD4/CD8↓RelapseofNStriggeredbyavarietyofminorinfectionsAutologousremissionaftermeaslesInductionofremissionbycorticosteroidsandakylatingagents
MCN:pathogenesisofproteinuriaLymphacyte→29kdpeptide→glomerularpolyanion↓→proteinuriaConA→lymphacytes→60-160kdGPF→proteinurialymphacytes→13-18kdSIRS→proteinuriaGPF:glomerularpermeabilityfactorSIRS:solubleimmuneresponsesuppressorMCN:pathogenesisofedemaFFNa↓,CH2O↓
Edema
Proteinuria
Nareabsorptionindistalrenaltubules
Naandwaterretention
Edema
Hypoalbuminemia
intravascularoncoticpressure↓(25mmHg→6-8mmHg)
Fluidextravasation
hypovolemia
ADHandaldosterone
Waterandsaltretension
Edema
MCN:pathogenesisofhypoalbuminemiaMCN:pathogenesisofhyperlipidemiaHypoalbuminemia→hypaticsynthesisoflipid↑→hyperlipidemiaClinicalManifestation
Simplenephrosis:2--7y,massiveedemainfaceandparaorbitalareas,ascites,pleuraleffusion,lossofappetite,nauseaandvomiting,inertiaandlethargyNephriticnephrosis:>7y,moderateedema,grosshematuria,hypertensionComplications:Complications(1)Infection:URI,peritonitis,cellulitisandetc
IgG
,IgA
,Complement
WBCfunction
LackofZnandothertraceelementsHypercoagulablestateandthrombosis
HigherconcentrationofⅤ,Ⅶ,Ⅷ,ⅩLowerlevelofanticoagulantsubstance:antithrombinⅢ,proteinS,proteinCOvervigorousdiuresisHigherbloodviscosity,increasedplateletaggregationRoleofcorticosteroidsComplications(2)Electrolyteimbalance:hyponatrimia,hypokalemia,hypercalcemiaSalt-depleteddietOvervigorousdiuresisExtrarenallossProtein-boundcalciumlossfromurineSteroidsinducedhypocalcemiaARF:pre-renalHypovolemicshockOthers:growthfailureLaboratoryData(1)ESR:simplenephrosis>100mm/h,nephriticnephrosis<100mmHgSerumpreoteinelectrophoresis:
2
,
,
insimplenephrosisbut
innephriticNephrosisImmunoglobulin:IgG
,IgA
,IgM
IgA>IgM,C3
nephriticnephrosisIgM>IgA,normalC3
simplenephrosisLaboratoryData(2)Renalfunction:usuallynormalUrineproteinpattern:simplenephrosis
albuminnephriticnephrosis
IgG,albuminandothersRatioofUIgG/Ualbuminsimplenephrosis
<1nephriticnephrosis
>1DiagnosisanddifferentialdiagnosisIdiopathicorsecondaryMCNornon-MCNimportanceofrenalbiopsyTreatmentofNSGeneralprincipleAnticoagulationCorticosteroidsImmunosuppressiveagentsChinesetraditionalmedicineGeneralprincipleLowsaltdiet(2g/d),appropriateproteinintake(2-3g/kg/d)AvoidinginfectionDiuresis:Thiazide–DHCT2mg/kg/dAntisterone2-4mg/kg/dDextran10-20ml/kgfollowedbyLasixat2mg/kgAnticoagulation
Dipyridamole:5mg/kg/dHeparin:0.5-1mg/kg/d×7-10dWarfarin:initialdose:2.5mgTid×3-5dSubsequentdose:2.5-10mg/dbasedonPTCorticosteroidsShortcourse:2mg/kg/d→pro(-)1.5mg/kg/qod×4w→notaper,Course<8w,Relapserate(1y)=81%Standardcourse:2mg/kg/d×4w→2mg/kg/qod×4w→taper,
Course<6m,Relapserate(1y)=61%Longcourse:2mg/kg/d×4-6w→2mg/kg/qod×4-6w→taper,
Course<9-12m,Relapserate(1y)=31%Steroidstreatmentresponse
highresponse:4w→proteinuria(-)response:8w→proteinuria(-)partialresponse:8w→proteinuria(+/++)steroiddependent:responsivebutrequirehighdoserelapse:proteinuria(-)→proteinuria(++orup)frequentrelapse:relapsetwice/6mortrice/1ySideeffectofsteroidsGrowthfailureHypertensionposteriorsublenticularcataractsOsteoporoticbonediseaseGastriculcer→hematesis
Immunosuppressiveagents(1)CTX:2-2.5mg/kg/d×8-12w,maxiumsingledose0.1,maxiumcumulative200-250mg/kgChlorambucil:0.2mg/kg/d×8-12w,maxiumsingledose6mg,maxiumcumulativedose12-16mg/kgCyclosporinA:5-6mg/kg/d×2-6m,keepbloodconcentrationat50-150ng/mlImmunosuppressiv
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 神經(jīng)系統(tǒng)疾病護理要點課件
- 助產(chǎn)專業(yè)婦科護理倫理與法律
- 兒童飲食與肥胖預(yù)防
- 兒科肺炎護理中的病情觀察
- 肝癌介入治療的心理護理與溝通
- 產(chǎn)婦術(shù)后用藥安全須知
- 陜西省2025八年級物理上冊第二章光現(xiàn)象第四節(jié)光的反射第2課時光的反射定律鏡面反射和漫反射課件新版蘇科版
- 手足口病護理案例分享
- 機房精密空調(diào)培訓(xùn)課件
- 護理質(zhì)量與安全領(lǐng)導(dǎo)力培養(yǎng)
- 小學(xué)生必讀書試題及答案
- 銷售部年終總結(jié)及明年工作計劃
- 工作計劃執(zhí)行跟蹤表格:工作計劃執(zhí)行情況統(tǒng)計表
- (完整版)現(xiàn)用九年級化學(xué)電子版教材(下冊)
- 城市道路路基土石方施工合同
- 教學(xué)計劃(教案)-2024-2025學(xué)年人教版(2024)美術(shù)一年級上冊
- 國家基本公共衛(wèi)生服務(wù)項目之健康教育
- DL∕ T 1166-2012 大型發(fā)電機勵磁系統(tǒng)現(xiàn)場試驗導(dǎo)則
- 新人教版日語七年級全一冊單詞默寫清單+答案
- HJ 636-2012 水質(zhì) 總氮的測定 堿性過硫酸鉀消解紫外分光光度法
- QBT 2739-2005 洗滌用品常用試驗方法 滴定分析 (容量分析)用試驗溶液的制備
評論
0/150
提交評論